COMMUNIQUÉS West-GlobeNewswire

Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
23/07/2026
CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will [...]
Cato Supply Rebrands as Cato Healthcare Supply to Reflect Expanded Mission of Protecting Hospital Revenue Through Supply Chain Resilience
23/07/2026
DALLAS, July 23, 2026 (GLOBE NEWSWIRE) -- Cato Supply Inc. today announced its official rebrand to Cato Healthcare Supply , a strategic evolution that better reflects the company's mission. Cato stands for Completely [...]
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
23/07/2026
Additional Platform Deployment at Major Academic Medical Center Reflects Increasing Commercial Demand for Bedside Feeding Tube Navigation TYLER, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ [...]
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
23/07/2026
Company has addressed final review items from penetration testing and finalized cybersecurity and software documentation 510(k) package submission on track for calendar H2 2026, targeting planned entry into multi- [...]
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
23/07/2026
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter [...]
NewGen’s Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai’s Valuation Reaches US$200 Million
23/07/2026
K25.ai closes Series A investment round, reaching a post-money valuation of US$200 million NewGen’s 10% ownership stake in K25.ai has reached US$20 million in value and generated a ~US$10 million unrealized gain, [...]
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
Conference call scheduled for 4:30 p.m. Eastern Time WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX) (“Ardelyx” or the “Company”), a commercial-stage biopharmaceutical company focused on [...]
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
23/07/2026
CLEARWATER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics marketed and sold as Renuvion ® and the AYON Body [...]
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
23/07/2026
Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications THE WOODLANDS, TX, [...]
Revolver Brewing Becomes Revolver Beer and Spirits, Extending the Blood & Honey Brand into Whiskey, Gin and Vodka
23/07/2026
New spirits line brings the bold blood orange and honey profile of Revolver’s iconic Blood & Honey beer to Whiskey, Gin and Vodka launching exclusively in Texas BRECKENRIDGE, Colo., July 23, 2026 (GLOBE NEWSWIRE [...]
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
23/07/2026
LAS VEGAS, July 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a developer of science-driven wellness products, today announces the successful completion of its commercial manufacturing and [...]
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026
First global approval of a once-daily, orally administered, Complement Factor B inhibitor Approval based on robust efficacy and safety data from Haisco's broad completed clinical development program in PNH Ciprocopan [...]
Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing
23/07/2026
Healthcare Holding Schweiz AG, a leading Swiss service provider and distributor of medical technology, has successfully closed a CHF 80 million syndicated financing. Healthcare Holding Schweiz is managed by Winterberg [...]
NMD Pharma Announces Publication Identifying Neuromuscular Junction Transmission Failure as a Novel Contributor to Age-Related Muscle Weakness
23/07/2026
New publication identifies neuromuscular junction transmission failure as a novel mechanism contributing to sarcopenia, with preclinical studies showing that ClC-1 inhibition improves neuromuscular transmission and [...]
VERAXA Biotech Appoints Christoph Erkel as Chief Scientific Officer to Advance BiTAC® Technology Platforms and Portfolio
23/07/2026
ZURICH, SWITZERLAND, July 23, 2026 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Christoph Erkel, Ph.D., as [...]
Commure Wins Two Stevie® Awards for Technology Excellence, Including Gold for Company of the Year in Healthcare Technology
23/07/2026
CEO Tanay Tandon honored as Executive of the Year MOUNTAIN VIEW, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Commure , the leading AI-native healthcare RCM & Ambient platform, today announced it has been recognized [...]
ZoomRx Launches Signal-IQ: Competitive Field Intelligence, Delivering Real-Time NPI-Level Visibility into Competitor Sales Force Activity for Pharma Commercial Teams
23/07/2026
BOSTON, July 23, 2026 (GLOBE NEWSWIRE) -- ZoomRx, a strategic life sciences consultancy trusted by 100+ leading biopharma companies across the world, today announced the launch of Signal-IQ: Competitive Field [...]
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
23/07/2026
LONDON and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
23/07/2026
JUPITER, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2026 financial results on Thursday, August 6, 2026. The company will [...]

Pages